Company intelligence / Profile preview

Inolase

Schaan, Liechtenstein

Ownership: Private
Development stage: Other

Overview

Inolase is a medical technology company based in Liechtenstein that specializes in the development and commercialization of advanced laser systems for dental and medical applications. The company's flagship product is a high-performance diode laser designed specifically for minimally invasive treatments in periodontology, endodontics, and implantology. By utilizing specific wavelengths, Inolase technology enables effective decontamination and tissue management with reduced patient discomfort and faster healing times. The company focuses on providing clinicians with precise tools that integrate seamlessly into modern dental workflows to improve clinical outcomes in treating chronic oral infections.

Therapeutic areas: Infectious Diseases
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Inolase.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inolase.

Explore the full profile